Insider Transactions in Q4 2024 at Bridge Bio Pharma, Inc. (BBIO)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 10
2024
|
Thomas Trimarchi President and COO |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+10.46%
|
-
|
|
Nov 19
2024
|
Neil Kumar Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
27,389
-0.28%
|
$602,558
$22.58 P/Share
|
|
Nov 19
2024
|
Brian C Stephenson Secretary, Treasurer & CFO |
SELL
Open market or private sale
|
Direct |
4,156
-4.24%
|
$91,432
$22.41 P/Share
|
|
Nov 16
2024
|
Neil Kumar Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
28,148
-0.57%
|
$647,404
$23.72 P/Share
|
|
Nov 16
2024
|
Neil Kumar Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
55,537
+1.11%
|
-
|
|
Nov 16
2024
|
Thomas Trimarchi President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
17,936
-4.53%
|
$412,528
$23.72 P/Share
|
|
Nov 16
2024
|
Brian C Stephenson Secretary, Treasurer & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
13,077
-11.78%
|
$300,771
$23.72 P/Share
|
|
Nov 16
2024
|
Brian C Stephenson Secretary, Treasurer & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,799
+18.86%
|
-
|